DCF — ARISE AUSTIN MEDICAL CENTER
Enterprise Value: $2.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$2.0M
Enterprise Value
$-0.0M
PV of Cash Flows
$2.0M
PV of Terminal Value
$3.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $25.3M | $0.8M | 3.0% | $-0.3M | $-0.3M |
| Year 2 | $26.1M | $1.1M | 4.0% | $-0.1M | $-0.1M |
| Year 3 | $26.8M | $1.4M | 5.0% | $0.1M | $0.1M |
| Year 4 | $27.6M | $1.6M | 6.0% | $0.2M | $0.1M |
| Year 5 | $28.5M | $1.7M | 6.0% | $0.2M | $0.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $2.0M. Terminal value accounts for 102% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$24.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.026912438636133403
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5